Live Breaking News & Updates on Sense Therapeutics Ltd

Stay updated with breaking news from Sense therapeutics ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Comparing NeuroSense Therapeutics (NASDAQ:NRSN) and Phathom Pharmaceuticals (NASDAQ:PHAT)

Comparing NeuroSense Therapeutics (NASDAQ:NRSN) and Phathom Pharmaceuticals (NASDAQ:PHAT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , Tel Aviv , Florham Park , Phathom Pharmaceuticals , News Ratings For Phathom Pharmaceuticals Daily , Neurosense Therapeutics Ltd , Phathom Pharmaceuticals Inc , Get Free Report , Neurosense Therapeutics , Given Phathom Pharmaceutical , Neurosense Therapeutic , Sense Therapeutics , Sense Therapeutics Ltd , Phathom Pharmaceuticals Daily ,

NeuroSense Therapeutics Ltd. (NASDAQ:NRSNW) Short Interest Down 57.1% in March

NeuroSense Therapeutics Ltd. (NASDAQ:NRSNW – Get Free Report) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 1,800 shares, a decline of 57.1% from the March 15th total of 4,200 shares. Based on an average daily volume of 10,000 shares, the short-interest ratio […] ....

United States , Neurosense Therapeutics Company Profile , Neurosense Therapeutics Ltd , Neurosense Therapeutics , Get Free Report , Sense Therapeutics , Sense Therapeutics Ltd , Neurosense Therapeutics Daily , Nasdaq Nrsnw ,

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Short Interest Down 17.7% in January

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 205,200 shares, a decline of 17.7% from the December 31st total of 249,200 shares. Approximately 2.3% of the shares of the company are short sold. Based […] ....

United States , Neurosense Therapeutics Ltd , Renaissance Technologies , Vanguard Personalized Indexing Management , Millennium Management , Neurosense Therapeutics , Get Free Report , Sense Therapeutics , Montreal Can , Sense Therapeutics Ltd , Neurosense Therapeutics Daily , Nasdaq Nrsn ,

NeuroSense Therapeutics (NASDAQ:NRSN) Coverage Initiated at Alliance Global Partners

Stock analysts at Alliance Global Partners began coverage on shares of NeuroSense Therapeutics (NASDAQ:NRSN – Get Free Report) in a report issued on Monday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. NeuroSense Therapeutics Trading Up 0.7 % NeuroSense Therapeutics stock opened at $1.39 on Monday. The stock has a 50-day moving […] ....

United States , Neurosense Therapeutics Ltd , Millennium Management , Alliance Global Partners , Vanguard Personalized Indexing Management , Neurosense Therapeutics Company Profile , Neurosense Therapeutics , Get Free Report , Sense Therapeutics , Montreal Can , Personalized Indexing Management , Jane Street Group , Sense Therapeutics Ltd , Neurosense Therapeutics Daily , Nasdaq Nrsn , Initiated Coverage ,